[PTEN induces anoikis through its phosphatase activity in hepatocellular carcinoma cells]

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern.
• Anoikis, a form of apoptosis, plays a role in preventing cancer metastasis.
• The tumor suppressor gene PTEN is frequently inactivated in various cancers, including HCC.

Purpose of the Study:

• To elucidate the role of the PTEN gene in inducing anoikis in hepatocellular carcinoma SMMC-7721 cells.
• To investigate the underlying molecular mechanisms involving FAK and Akt signaling pathways.

Main Methods:

• Transfection of SMMC-7721 cells with wild-type PTEN or a phosphatase-inactive mutant (C124A-PTEN).
• Western blotting to assess PTEN expression and phosphorylation levels of FAK and Akt.
• Flow cytometry and confocal microscopy to quantify apoptosis in adherent and non-adherent cells.

Main Results:

• Overexpression of wild-type PTEN significantly increased anoikis percentage (9.5% to 31.3%).
• PTEN overexpression led to decreased phosphorylation of FAK (by 65.2%) and Akt (by 89.1%).
• The phosphatase-inactive PTEN mutant did not significantly alter FAK/Akt phosphorylation or anoikis rates.

Conclusions:

• PTEN's phosphatase activity is crucial for suppressing FAK and Akt phosphorylation.
• PTEN effectively induces anoikis in hepatocellular carcinoma cells.
• Targeting PTEN signaling may offer therapeutic strategies for HCC.